Cargando…

Critical examination of incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada

Detalles Bibliográficos
Autores principales:	Morin, Kristen A., Leary, Tara, Marsh, David C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2023
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610954/ https://www.ncbi.nlm.nih.gov/pubmed/37816522 http://dx.doi.org/10.1503/cmaj.149149

Ejemplares similares

Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada
por: Palis, Heather, et al.
Publicado: (2023)

Prescription de psychostimulants aux personnes présentant un trouble lié à l’utilisation de stimulants dans le continuum de soins au Canada
por: Palis, Heather, et al.
Publicado: (2023)

Psychostimulants and Movement Disorders
por: Asser, Andres, et al.
Publicado: (2015)

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk
por: Tardelli, Vitor, et al.
Publicado: (2023)

Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder
por: Petković, Branka, et al.
Publicado: (2020)

Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited
por: Bahji, Anees, et al.
Publicado: (2023)

The authors respond to letters on using prescribed psychostimulants to treat stimulant use disorder
por: Palis, Heather N., et al.
Publicado: (2023)

Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2021)

Differences in addictive beliefs in people with psychostimulant addiction and in opioid addicts
por: Yan, Y., et al.
Publicado: (2022)

Psychostimulant Drugs and Neuroplasticity
por: Fernandez-Espejo, Emilio, et al.
Publicado: (2011)

Too much or never enough: a response to Treatment of opioid disorders in Canada: looking at the ‘other epidemic’
por: Eibl, Joseph K., et al.
Publicado: (2016)

Risk of Tics with Psychostimulants for ADHD
por: Millichap, J. Gordon
Publicado: (2015)

Binge eating and psychostimulant addiction
por: Blanco-Gandia, M Carmen, et al.
Publicado: (2021)

Role of Microglia in Psychostimulant Addiction
por: Machado da Silva, Maria Carolina, et al.
Publicado: (2023)

Attention-deficit hyperactivity disorder and use of psychostimulants among children in Turkey
por: Aras, Sahbal, et al.
Publicado: (2007)

Examining Access to Primary Care for People With Opioid Use Disorder in Ontario, Canada: A Randomized Clinical Trial
por: Spithoff, Sheryl, et al.
Publicado: (2022)

The Role of Adenosine Receptors in Psychostimulant Addiction
por: Ballesteros-Yáñez, Inmaculada, et al.
Publicado: (2018)

The Use of Drosophila to Understand Psychostimulant Responses
por: Philyaw, Travis James, et al.
Publicado: (2022)

The role of serotoninergic system in psychostimulant effects
por: Taracha, Ewa
Publicado: (2021)

Dysfunction of the Neurovascular Unit by Psychostimulant Drugs
por: Vo, Tam Thuy Lu, et al.
Publicado: (2023)

The Therapeutic Potential of Amphetamine-like Psychostimulants
por: Pires, Bruno, et al.
Publicado: (2023)

Dysregulation of Acetylation Enzymes in Animal Models of Psychostimulant use Disorders: Evolving Stories
por: Cadet, Jean Lud
Publicado: (2016)

Psychostimulants/Atomoxetine and Serious Cardiovascular Events in Children with ADHD or Autism Spectrum Disorder
por: Houghton, Richard, et al.
Publicado: (2019)

Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?
por: Hersey, Melinda, et al.
Publicado: (2021)

Cocaine- and Amphetamine-Regulated Transcript (CART) Peptide Plays Critical Role in Psychostimulant-Induced Depression
por: Meng, Qing, et al.
Publicado: (2018)

Behavioral effects of ketamine and toxic interactions with psychostimulants
por: Hayase, Tamaki, et al.
Publicado: (2006)

Is there potential for the treatment of children with ADHD beyond psychostimulants?
por: Hoekstra, Pieter J.
Publicado: (2011)

The Health Effect of Psychostimulants: A Literature Review
por: Favrod-Coune, Thierry, et al.
Publicado: (2010)

Ghrelin and ghrelin receptor modulation of psychostimulant action
por: Wellman, Paul J., et al.
Publicado: (2013)

The Involvement of Norepinephrine in Behaviors Related to Psychostimulant Addiction
por: Zaniewska, Magdalena, et al.
Publicado: (2015)

Role of nitric oxide in psychostimulant-induced neurotoxicity
por: Bashkatova, Valentina, et al.
Publicado: (2019)

S95. DIFFERENCES IN LIFETIME PATTERNS OF PSYCHOSTIMULANTS AND THEIR IMPACT ON THE PROPORTION OF PATIENTS WITH FIRST-EPISODE PSYCHOSIS ATTRIBUTABLE TO PSYCHOSTIMULANTS USE ACROSS EUROPE
por: Duran-Cutilla, Manuel, et al.
Publicado: (2020)

The continuum of critical care
por: Vincent, Jean-Louis
Publicado: (2019)

Treatment of prescription opioid disorders in Canada: looking at the ‘other epidemic’?
por: Fischer, Benedikt, et al.
Publicado: (2016)

Case Report: Treatment of a Comorbid Attention Deficit Hyperactivity Disorder and Obsessive–Compulsive Disorder With Psychostimulants
por: Dogan-Sander, Ezgi, et al.
Publicado: (2021)

Building an inpatient addiction medicine consult service in Sudbury, Canada: preliminary data and lessons learned in the era of COVID-19
por: Leary, Tara, et al.
Publicado: (2023)

The opioid crisis: past, present and future policy climate in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2017)

Role of the ERK pathway in psychostimulant-induced locomotor sensitization
por: Valjent, Emmanuel, et al.
Publicado: (2006)

CART Peptides Regulate Psychostimulants and May be Endogenous Antidepressants
por: M.O, Job, et al.
Publicado: (2011)

Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity
por: Kalivas, Peter W.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_7chi1ovq9055tlfds0vp0jeaba